IM PEARLS Flashcards
Underlying cause of Chest Pain in Stable Angina
Fixed atherosclerotic stenosis of coronary arteries - Increased myocardial oxygen demand - LACTIC ACIDOSIS
Precursor lesion of atherosclerosis
FATTY STREAK containing foam cells (macrophages)
Why does pain radiate to the left arm in Stable Angina
Synapses shared with C4 and C5 sensory fibers
What does pain radiating to the upper back (trapezius) indicate?
PERICARDIAL involvement
Major Risk Factors for Chronic Stable Angina
DM, SMOKING, family history of CAD or premature CAD (M<50(F)
Minor Risk Factor for Chronic Stable Angina
Age, Obesity (independent RF), Estrogen Deficiency (Males & Menopaused), Homocysteinemia
Best initial test for Stable Angina; What are the Expected Findings?
ECG showing ST DEPRESSION, FLATTENING OF T WAVES sec to ischemia
Expected Findings on Cardiac Enzymes in Stable Angina
Cardiac Enzymes NOT ELEVATED
Next best step in management of Stable Angina if ECG is nondiagnostic
EXCERCISE STRESS TESTING or Treadmill Stress Test (for MI Risk Stratification: (+) High Risk, (-) Low Risk)
If unable to walk, what stress test will you order in a Stable Angina patient?
DOBUTAMINE or DYPRIDAMOLE Stress Test (Increase Heart Rate and Contractility)
Stable Angina patient has BASELINE ECG ABNORMALITIES, what stress test is appropriate?
NUCLEAR STRESS TEST (Thallium, Sestamibi)
Most Appropriate Treatment in Stable Angina
LIFESTYLE MODIFICATION, OPD: Aspirin, Beta Blockers, Statins, Nitrates - Symptomatic Relief; NO Mortality Risk Reduction
Complications associated with Stable Angina
ACUTE MYOCARDIAL INFARCTION, ANEURYSMS
Patient’s chest pain unrelieved by rest or nitrates
UNSTABLE ANGINA (Crescendo Angina)
If Stress Test is Positive, what is the next Best Step in Management?
ANGIOGRAPHY (Preventive in MI), start ANTICOAGULATION, ASPIRIN, CLOPIDOGREL, NITRATES and BETA BLOCKERS
Underlying pathology in MI
RUPTURED ATHEROSCLEROTIC PLAQUE
Blood vessel involved in Acute MI
LEFT ANTERIOR DESCENDING ARTERY
Heart Wall involved in Acute MI
ANTEROSEPTAL WALL
Heart Wall involved in ECG Leads V1, V2
SEPTAL WALL (supplied by Left Anterior Descending)
Heart Wall involved in ECG Leads V3, V4
ANTERIOR WALL (supplied by Left Anterior Descending)
Heart Wall involved in ECG Leads II, III, aVF
INFERIOR WALL (supplied by Right Coronary Artery)
Heart Wall involved in ECG Leads I & aVL, V5 & V6
LATERAL WALL (supplied by Left Circumflex Artery)
2 Forms of Acute MI: Distinguish the two.
STEMI: Q Waves, new LBBB, ST elevations in 2 or more contiguous leads or chest leads (Noncontiguous Leads=PERICARDITIS); NSTEMI: T Wave inversion, ST Depression
Which patient population will MI present in atypical fashion?
ELDERLY (Autonomic Nervous System manifestations are subtle or irregular) and DIABETICS
Cardiac Enzymes requested in Acute MI
TROPONINS & CM-MB
Rise within 4 hours, detectable for 2 weeks, BEST marker for RECENT MI (artificially increased in CKD)
TROPONINS
Rise within 4 hours, peaks at 24 hours, normalizes in 2-3 days, BEST marker for REINFARCTION
CK-MB
Most Important initial intervention at the ER for Acute MI
MONA - Morphine, Oxygen, Nitrates (CI in Inferior Wall MI due to hypotension sec to decreased preload), Aspirin
GOLD STANDARD in treatment of Acute MI
PERCUTANEOUS CORONARY INTERVENTION (if brought to ER within 90 minutes)
Difference of Management in STEMI & NSTEMI
STEMI: PCI or Thrombolysis if PCI not available (most effective at 6 hours, effective up to 12 hours), anticoagulation with Heparin; NSTEMI: PCI, anticoagulation with Heparin (thrombolysis has NO benefit in NSTEMI)
Absolute Contraindication to Thrombolysis in Acute MI
Hemorrhagic CVD, Brain Tumor, Head Trauma, Ischemic CVD within last 1 year, Active Bleeding (exc Menses), Aortic Dissection, BP Cutoff >180/110mmHg
Medication shown to Improve Acute MI Survival
ASPIRIN, BETA BLOCKERS (Dec Demand), ACE(prevent CHF)/ARBs (if with LV dysfunction)
Acute Complications of Acute MI
PUMP FAILURE (Acute CHF; Inpatients) & ARRHYTHMIAS (Ventricular Fibrillation; Outpatients)
How is Extent of Pump Failure Stratified?
KILLIP CLASSIFICATION - I: No evidence of HF; II: Mild to moderate HF (S3 Gallop, Lung Rales, or JVD); III: Overt pulmonary edema; IV: Cardiogenic Shock
Why is there Pulmonary Edema in Acute MI
PUMP FAILURE (LV Dysfuntion) - Backflow of Blood into Pulmonary Vessels
Associated Complications for Acute MI
Myocardial Aneurysm, Papillary Muscle Rupture, Rupture of Interventricular Septum, Free Wall Rupture, Pericarditis (Dressler Syndrome)
2-7 Days post MI, MCC: Inferior Wall Ischemia, Sx: Pansystolic Murmur radiating to Axilla, Mitral Regurg Murmur, Dx: 2D Echo, Tx: Surgical Repair
PAPILLARY MUSCLE RUPTURE
3-5 days post MI, MCC: Anterior Wall MI, Sx: Acute R-Sided CHF, Harsh holosystolic murmur in LLSB, thrill, Tx: Balloon Catheterization, Surgical Repair
RUPTURE OF IV SEPTUM (Benign)
5 days-2 weeks post MI, MCC: Lateral Wall MI, Sx: Sudden chest pain, Acute HF, Hemopericardium, Tamponade, PEA, Death 90%, Tx: Pericardiocentesis, Emergency Thoracotomy
FREE WALL RUPTURE
1 month post MI, Sx: Persistent ST elevation, Tx: Warfarin, Surgical Repair
MYOCARDIAL ANEURYSM
Weeks to Months post MI, Sx: Pleuritic chest pain, Pericardial Friction Rub, Fever, Tx: High-Dose Aspirin, Ibuprofen (NSAIDS)
DRESSLER SYNDROME
Management for Severe Bleeding upon Heparinization of Acute MI patient
Stop Heparin. Give PROTAMINE SULFATE.
Management of Thrombocytopenia upon Heparinization of Acute MI patient
Stop Heparin. Give LEPIRUDIN/ ARGATROBAN
Underlying cause of Congestive Heart Failure
VENTRICULAR DYSFUNCTION sec to CORONARY ARTERY DISEASE/ HYPERTENSION
Congestive Heart Failure caused by a pulmonary etiology
COR PULMONALE
Histopathologic change of CHF
CONCENTRIC (Inc Cardiac Muscle Width) LV HYPERTROPHY due to Pressure Overload (contrast to Eccentric {Dilation of Chamber} LVH in Hyperthyroidism) & SIDEROPHAGES (Hemosiderin-laden macrophages or HEART FAILURE CELLS)
Forms of CHF
SYSTOLIC (Weak LV) vs DIASTOLIC (hear unable to accommodate, does not relax enough) HF; LOW OUTPUT vs HIGH OUTPUT HF; LEFT-SIDED vs RIGHT-SIDED HF
Differentiaten Systolic from Diastolic Heart Failure
Systolic HF has LOW EF (40-50%)
Differentiate Low from High Output Heart Failure
LOW OUTPUT HF has CO 3L/MIN PER M2 (Hyperthyroidism, Anemia, Beri-Beri, Pregnancy, AV Fistula)
Differentiate Left from Right-Sided HF
Left-Sided HF: PULMONARY CONGESTION, ORTHOPNEA, WEAKNESS; Right-Sided HF: PERIPHERAL EDEMA, CONGESTIVE HEPATOMEGALY, SYSTEMIC VENOUS DISTENTION
Assessment of Functional Status of CHF
NYHA FUNCTIONAL CLASSIFICATION: I- No Limitation of Physical Activity, II- Slight Limitation of Physical Activity, III- Marked Limitation of Physical Activity, IV- Complete Limitation of Physical Activity (Symptomatic even at rest)
Criteria for Diagnosis of CHF
FRINGHAM CRITERIA: MAJOR (PRINCES H) - Paroxysmal nocturnal dyspnea, Rales, Increased CVP, Neck vein distention, Cardiomegaly, acute pulmonary Edema, S3 Gallop, Hepatojugular Reflux; MINOR - bipedal edema, night cough, dyspnea on exertion, hepatomegaly, pleural effusion, decreased vital capacity, tachycardia, weight loss
ORTHOPNEA in CHF
Redistribution of fluid from splanchic circulation and lower extremities into central during recumbency
PAROXYSMAL NOCTURNAL DYSPNEA in CHF
Inc Pressure in Bronchial Arteries -> Airway Compression with Interstitial Pulmonary Edema
Irregular Pattern of Respiration seen in CHF
CHEYNE-STOKE RESPIRATION due to Diminished Sensitivity of Respiratory Center to Arterial PCO2
CRACKLES in CHF
Transudation of fluid from intravascular space into he alveoli
ABDOMINAL PAIN In CHF
Chronic passive congestion of liver lead to distention of Glisson’s Capsule (pain-sensitive)
Most important Diagnostic Test in CHF
2D ECHOCARDIOGRAPHY (EJECTION FRACTION)
Use of Brain Natreuretic Peptide in CHF
Differentiates cardiogenic from noncardiogenic pulmonary edema during shortness of breath (Normal BNP excludes CHF as cause of shortness of breath)
Most likely seen on Chest Xray in CHF
CARDIOMEGALY, PULMONARY CONGESTION (pulmonary vessel markings at apex), KERLEY B LINES
Most important treatment for pulmonary edema in CHF
LOOP DIURETICS (FUROSEMIDE)
Treatment modalities shown to decrease mortality in CHF
ACE-Is/ARBs (EF<35 in FC IV)
Drug that decreases hospitallization but has no effect on overall mortality of CHF patients
DIGOXIN
Heart valve involved in Infective Endocarditis
TRICUSPID VALVE
Most common microbial etiology in Infective Endocarditis
STAPHYLOCOCCUS AUREUS
Complications of Infective Endocarditis
RUPTURE OF CHORDAE TENDINAE, SEPTIC EMBOLISM
Virulence Factor of Causative Organism in IE that conveys Penicillin Resistance
PENICILLINASE
Virulence Factor of the Causative Organism in IE that conveys Complement Inactivation
PROTEIN A
Virulence Factor of Causative Organism in IE that conveys Ability to Cause Chordae Rupture
HYALURONIDASE
Most Common Cause of Acute IE? In IV Drug Abusers?
BOTH STAPHYLOCOCCUS AUREUS
Most Common Cause of Subacute IE? In Native-Valve IE?
BOTH VIRIDANS STREP
Most Common Cause of Prosthetic Valve IE
STAPHYLOCOCCUS EPIDERMIDIS
Most Common Cause of Culture-Negative IE
HACEK
Most Common Cause of IE in Colon Cancer Setting
S. BOVIS (MARANTIC ENDOCARDITIS)
IE in GIT Surgery
ENTEROBIUS FAECALIS
IE in SLE patient setting
LIBMAN-SACKS ENDOCARDITIS or VERRUCOUS ENDOCARDITIS
Best initial test for Infective Endocarditis
TRANSTHORACIC ECHOCARDIOGRAPHY
Other Diagnostic Test may be needed for Diagnosis of IE
BLOOD CULTURES from 2 NON-CONTIGUOUS SITE
Clinical Criteria for Diagnosis of IE
DUKE’S CRITERIA: MAJOR - 2 Positive Blood Culture, Positive Echocardiography (Vegetations); MINOR - Predisposing valve abnormality, Fever, Vascular Phenomena, Immunologic Phenomena, One Positive Culture, Suggestive Echocardiography
Vascular Phenomena associated with IE
MAJOR ARTERIAL EMBOLI, SEPTIC PULMONARY INFARCTS, MYCOTIC ANEURYSM, INTRACRANIAL HEMORRHAGE, CONJUNCTIVAL HEMORRHAGE, SPLINTER HEMORRHAGE, JANEWAY LESIONS
Immunologic Phenomena associated with IE
GLOMERULONEPHRITIS, OSLER’S NODES, ROTH’S SPOTS, RHEUMATOID FACTOR
Most Appropriate Empiric Therapy for IE until Culture is available
VANCOMYCIN + GENTAMICIN
Considered High-Risk Patiets requiring Prophylaxis before a Dental Procedure
PROSTHETIC VALVES, PRIOR IE, UNREPAIRED CYANOTIC CHD, RECENTLY-REPAIRED CHD, INCOMPLETELY-REPAIRED CHD, VALVULOPATHY POST-TRANSPLANT
Drug given for Standard Prophylaxis before Dental Procedures? If patient has Penicillin Allergy?
AMOXICILLIN; if WITH ALLERGY - CLINDAMYCIN or CLARITHROMYCIN
Underlying Cardiac Defect in RHD (Mitral Stenosis)
MITRAL VALVULAR DAMAGE DUE TO PREVIOUS RHEUMATIC FEVER
Histopathologic Changes in the Myocardium in RHD
“2 Russians”: ASCHOFF BODIES (ANITSCHKOW MYOCYTES)
Hemodynamic Changes occuring in the heart in RHD
INCREASED LEFT ATRIAL DIASTOLIC PRESSURE
Acute Rheumatic Fever Diagnosis
JONES CRITERIA: 2 Major or 1 Major & 2 Minor: MAJOR (JONES) - migratory polyarthritis (Joints), pancarditis (Oh my heart!), subcutaneous Nodules, Erythema marginatum, Sydenham’s chorea; MINOR - Arthralgia, Fever, Elevated ESR/CRP, Prolonged PR interval
Infection usually preceding ARF
STREPTOCOCCUS PYOGENES (GABHS) INFECTIONS - SKIN (IMPETIGO) or PHARYNGITIS
Pathophysiologic Mechanism of ARF
TYPE II REACTION ( IMMUNOLOGIC CROSS-REACTION due to STREPTOCOCCAL M PROTEIN)
Long term sequelae of repeated bouts of ARF characterized by Permanent Valvular Damage
RHEUMATIC HEART DISEASE
Most common Valvular Defects in ARF
MITRAL REGURGITATION
Most Common Valvular Defects in RHD
MITRAL STENOSIS
Best initial Test for RHD
2D ECHOCARDIOGRAPHY
Most Appropriate Treatment for RHD
SURGICAL REPAIR (VALVOTOMY, COMMISUROTOMY), ANTICOAGULATION, DIURETICS
Most common Valvular Heart Disease
MITRAL VALVE PROLAPSE (Most Common), MITRAL STENOSIS, MITRAL REGURGITATION, AORTIC STENOSIS, ATRIAL REGURGITATION
Conditions associated with MVP
EHLERS-DANLOS SYNDROME, MARFA. SYNDROME, POLYCYSTIC KIDNEY DISEASE
Murmur of MVP
MIDSYSTOLIC CLICK followed by MIDSYSTOLIC to LATE SYSTOLIC MURMUR at APEX
Murmur of Mitral Stenosis
OPENING SNAP followed by MID-DIASTOLIC RUMBLE, LOUD S1 and P2
Clinical Presentation of Mitral Stenosis
Usually ASYMPTOMATIC until ATRIAL FIBRILLATION or PREGNANCY develops
Murmur of Mitral Regurgitation
HOLOSYSTOLIC MURMUR at APEX radiating to AXILLA
Other signs of Mitral Regurgitation
HYPERDYNAMIC PRECORDIUM, BRISK CAROTID UPSTROKE
Murmur of Aortic Stenosis
EARLY SYSTOLIC EJECTION MURMUR at 2ND RIGHT ICS, radiating to CAROTIDS
Signs of Severe Aortic Stenosis
GALLAVARDIN PHENOMENON (Murmur disappears over sternum, reappears in apex) & PULSUS PARVUS ET TARDUS (small or weak pulse that rises slowly and delayed in occurence)
Murmur of Aortic Regurgitation
CORRIGAN PULSE: rapid rise and fall of carotid pulse; QUINCKE PULSE: subungual cappilary pulsations; DUROZIEZ SIGN: diastolic murmur over partially-compressed femoral artery; DE MUSSET SIGN: headbobbing with heartbeat; HILL SIGN: systolic BP >30mmHg in legs than arms; TRAUBE SIGN: pistol shot femoral pulses
Effect of Valsalva On murmur
INCREASES INTRATHORACIC PRESSURE, DECREASING VENOUS RETURN, DECREASING THE INTENSITY OF MURMURS
Effect of Squatting on Murmur
INCREASES VENOUS RETURN, INCREASING INTENSITY OF MURMURS
Pathophysiologic Type of Pericarditis
SEROUS, FIBRINOUS & HEMORRHAGIC
Most common infectious etiology of Pericarditis
COXSACKIE VIRUS TYPE B
Best initial test for Pericarditis? What are Expected Findings?
ECG showing DIFFUSE ST ELEVATIONS and PR DEPRESSION
Most appropriate treatment for Pericarditis
NSAIDS
Triad of Cardiac Tamponade
BECKS TRIAD: HYPOTENSION, JVD, DISTANT/MUFFLED HEART SOUNDS
Other Classic Signs of Cardiac Tamponade
PULSUS PARADOXUS (>10 mmHg fall in BP with inspiration), KUSSMAUL SIGN (sharp increase in JVP with inspiration), EWART SIGN (dullness, increased fremeti, egophony at left scapula), WATER BOTTLE HEART
ECG findings in Cardiac Tamponade
DECREASED QRS VOLTAGE AND ELECTRICAL ALTERNANS
Most appropriate treatment for Cardiac Tamponade
PERICARDIOCENTESIS
Differentiate Constrictive from Acute Pericarditis
CONSTRICTIVE PERICARDITIS PRESENTS WITH JVD, SIGNS OF RIGHT-SIDED HF and PERICARDIAL KNOCK (CALCIFIED OR CASTED PERICARDIUM)
Best initial step for Constrictive Pericarditis? Expected finding?
TRANSTHORACIC ECHOCARDIOGRAPHY showing INCREASED PERICARDIAL THICKNESS with CALCIFICATION
Most appropriate treatment for Constrictive Pericarditis
MILD CASES: Diuretics, ACE-Inhibitors SEVERE CASES: Pericardiectomy
Underlying cause for Acromegaly
Pituitary tumor secreting excess amount of GH
Important thing to compare in Acromegaly
COMPARE CURRENT APPEARANCE WITH OLD PHOTOS TO SEE DIFFERENCE IN FACI FEATURES
Loss of Peripheral Vision in Acromegaly
PITUITARY TUMOR compressing the OPTIC CHIASM, causing BITEMPORAL HEMIANOPSIA
Prone to Develop Carpal Tunnel Syndrome in Acromegaly
BONE OVERGROWTH COMPRESSES MEDIAN NERVE
Best initial test for Acromegaly
SERUM IGF-1 LEVELS
Best confirmatory Test for Acromegaly
SERUM GH after an OGTT (Glucose normally suppresses GH)
Most appropriate management for Acromegaly
TRANSSPHENOIDAL RESECTION OF TUMOR
Drug may be Given preoperatively to Shrink tumor size in Acromegaly
OCTREOTIDE (SOMATOSTATIN ANALOGUE)
Underlying cause for Prolactinoma
Pituitary tumor secreting excess amounts of PROLACTIN (antagonistic of GnRH)
Amenorrhea in Prolactinoma
DECREASED GnRH -> DEC FSH & LH -> INTERRUPTION OF MENSTRUAL CYCLE
Physiologic downregulators of Prolactin Secretion
DOPAMINE (antagonistic of Prolactin), ESTROGEN, PROGESTERONE, SOMATOSTATIN
Best initial management for Prolactinoma
Drug therapy with BROMOCRIPTINE or CABERGOLINE (DOPAMINE AGONISTS)
Drugs known to cause Secondary HyperProlactinemia
METOCLOPRAMIDE, AMITRYPTILINE, PHENOTHIAZINES, ANTIPSYCHOTICS
Underlying cause of SIADH
LUNG CANCER COMPOSED OF NEUROENDOCRINE CELLS -> AUTONOMOUS PRODUCTION OF EXCESS ADH
Decreased Sodium in SIADH
INCREASED WATER RETENTION -> DILUTIONAL HYPONATREMIA
Seizures in SIADH
Decreased Sodium creates osmotic gradient causing water movement into the brain -> CEREBRAL EDEMA
Underlying cause of DI
HEAD TRAUMA caused DESTRUCTION of the POSTERIOR PITUITARY GLAND
2 Types of DI
CENTRAL DI due to ADH Deficiency and NEPHROGENIC DI due to UNRESPONSIVENESS TO ADH
Distinguish between Central DI & Nephrogenic DI
WATER DEPRIVATION TEST: CENTRAL DI - Increased Urine Osmolality after ADH administration at the 6th hour of test; NEPHROGENIC DI - No increase in Urine Osmolality after ADH Administration at the 6th hour of test; PSYCHOGENIC POLYDIPSIA - increasing Urine Osmolality even if before ADH admin and further increase after ADH admin
Treatment for DI
CENTRAL DI: Give VASOPRESSIN; NEPHROGENIC DI: administer THIAZIDES (dec urine flow to DCT -> induce formation of functional ADH)
Drugs notorious for causing Nephrogenic DI
LITHIUM, DEMECLOCYCLINE
Underling cause for Grave’s Disease
AUTOANTIBODIES STIMULATE HYPERSECRETION OF THYROID HORMONES
Autoantibodies present in Grave’s
ANTI-TSH RECEPTOR ANTIBODIES
Drugs that cause similar condition as Grave’s
AMIODARONE, CLOFIBRATE, METHADONE
Drug of Choice for Grave’s? Feared Side Effect?
THIONAMIDES (PTU, MM); SE - AGRANULOCYTOSIS
Most Appropriate Diagnostic Test for Grave’s? Expected results?
Free T4, TSH (Increased FT4, Decreased TSH)
Most Appropriate Treatment for Grave’s
RADIOACTIVR IODINE ABLATION THERAPY
Expected treatment Complication of RAI used in Grave’s
SECONDARY HYPOTHYROIDISM
Drugs given preoperatively if Surgical Intervention contemplated in Grave’s
IODIDES to decrease Gland Vascularity
TRH Decrease, TSH Decrease, T4 Increase (Target Organs)
PRIMARY HYPERTHYROIDISM
TRH Decreased, TSH Increased, T4 Increased (Pituitary Problem)
SECONDARY HYPERTHYROIDISM
TRH Increased, TSH Increased, T4 Increased (Hypothalamic Problem)
TERTIARY HYPERTHYROIDISM
Weight Loss in Grave’s
EXCESS T3/T4 -> Increased CATABOLISM
Increased Sweating, Increased Bowel Movement & Tachycardia in Grave’s
EXCESS T3/T4 -> SYMPATHETIC OVERACTIVITY
Irregular Menses in Grave’s
EXCESS T3/T4 -> Inc Sex Hormone Binding Globulin levels, Inc Total Serum Estrogen -> Inc LH and Decreasing mid-cycle LH surge
Exophthalmos in Grave’s
Increased Volume of Retrobulbar Tissue due to Deposition of GAGs as a result of Lymphoytic Infiltration
Fine Finger Tremors in Grave’s
EXCESS T3/T4 -> Inc Synaptic Transmission and Inc Cerebration -> Reflex Oscillation of Muscle Spindles
Underlying Cause of Hypothyroiditis
Antibodies against Thyroglobulin and Thyroid Peroxidase lead to Autoimmune Destruction of Thyroid Gland
TRH Increased, TSH Increased, T4 Decreased (Target Organ Problem)
PRIMARY HYPOTHYROIDISM
TRH Increased, TSH Decreased, T4 Decreased (Pituitary Problem)
SECONDARY HYPOTHYROIDISM
TRH Decreased, TSH Decreased, T4 Decreased (Hypothalamic Problem)
TERTIARY HYPOTHYROIDISM
Fatigue and Weight Gain in Hypothyroidism
LOW T3/T4 -> DECREASED METABOLISM
Bradycardia in Hypothyroidism
LOW T3/T4 -> DECREASED SYMPATHETIC DRIVE
Coarse, Dry Skin in Hypothyroidism
LOW T3/T4 -> DECREASED HEAT PRODUCTION and DECREASED SWEATING
Depression in Hypothyroidism
LOW T3/T4 -> DECREASED SYNAPTIC TRANSMISSION IN BRAIN and DECREASED PRODUCTION OF NEUROTRANSMITTERS (SEROTONIN)
Amenorrhea in Hypothyroidism
LOW T3/T4 -> INCREASED TRH -> INC PROLACTIN, DEC GnRH, DEC FSH/LH
Bilateral Eyelid Edema
DEPOSITION OF GAGS as a result of LYMPHOCYTIC INFILTRATION of the CONNCECTIVE TISSUE of the SKIN
Underlying Cause of Hyperparathyroidism
PARATHYROID TUMOR SECRETING LARGE AMOUNTS OF PTH into BLOODSTREAM
Increased PTH, Increased s. Calcium, Decreased s. Phosphate (Target Organs Problem)
PRIMARY HYPERPARATHYROIDISM
Increased PTH, Decreased s. Calcium, Decreased s. Phosphate
SECONDARY HYPERPARATHYROIDISM (Pituitary Problem)
Depression and Fatigue in Hyperparathyroidism
UNKNOWN
Kidney Stones in Hyperparathyroidism
INCREASED URINARY CALCIUM CONCENTRATION
Muscle Weakness in Hyperparathyroidism
EXCESS PTH -> INCREASED PROTEIN BREAKDOWN and MUSCULAR ATROPHY
Other Expected Symptoms in Hyperparathyroidism
PAINFUL BONES, RENAL STONES, ABDOMINAL GROANS, PSYCHIATRIC OVERTONES
Most Appropriate Treatment in Hyperparathyroidism
SURGICAL PARATHYROIDECTOMY
Structure Injured during Surgical Treatment of Hyperparathyroidism
RECURRENT LARYNGEAL NERVE
Malignancy may Present Similarly with Hyperparathyroidism
HYPERCALCEMIA OF MALIGNANCY (usually SCCA OF LUNGS) due to PRODUCTION OF PTHrp (related protein)
Other Diseases that can Result in Secondary Forms of Hyperparathyroidism
CHRONIC KIDNEY DISEASE, CHRONIC PANCREATITIS. MALABSORPTION
Underlying Cause of Hypoparathyroidisn
INADVERTENT REMOVAL OF THE PARATHYROID GLAND DURING THYROID SURGERY
Decreased PTH, Decreased s. Calcium, Increased s. Phosphate
PRIMARY HYPOPARATHYROIDISIM
Decreased PTH, Increased s. Calcium, Increased s. Phosphate
SECONDARY HYPERPARATHYROIDISM
Muscle Twitching in Hypoparathyroidism
LOW SERUM CALCIUM -> INCREASED EXCITABILITY OF MOTOR NEURONS by DECREASING THRESHOLD POTENTIAL (HYPOCALCEMIC TETANY)
Underlying Cause of DM I
AUTOIMMUNE DESTRUCTION OF BETA CELLS IN PANCREAS, LEADING TO INSULIN DEFICIENCY
Increased Glucose, Decreased Insulin, Decreased C Peptide
TYPE 1 DM
Increased Glucose, Increased/Normal Insulin, Increased/Normal C Peptide
TYPE 2 DM
Bedwetting in DM
DUE TO OSMOTIC DIURETIC EFFECT OF GLUCOSE
Increased Urine Glucose in DM
TRANSPORT MAXIMA FOR GLUCOSE HAS BEEN REACHED
Weight Loss in DM
DECREASED INSULIN -> INCREASED PROTEIN DEGRADATION and MUSCLE WASTING
Polydipsia in DM
INCREASED THIRST AS A RESPONSE TO FREQUENT URINATION
Polyphagia in DM
DECREASED UPTAKE OF GLUCOSE INTO TARGET CELLS IN THE BODY TRIGGERS EXCESSIVE HUNGER
Delayed Age of Presentation in DM
RESIDUAL BETA-CELL FUNCTION (HONEYMOON PERIOD)
Diagnostic Test for DM
RBS with SSx, FBS >126, HbA1C >6.5, 2 HOUR 75g OGTT (most validated)
Most appropriate treatment
INSULIN REGIMEN, GLUCOSE MONITORING
Complications Expected if left Untreated
ACUTE SETTING: Diabetic Ketoacidosis CHRONIC COMPLICATIONS: Macro/Microvascular, Neuropathy, Cataracts, Nephropathy
Considerations in Early Morning Hyperglycemia
SOMOGYI EFFECT, DAWN PHENOMENON and WANING OF INSULIN
Irregular intake of meal at night with Insulin Admin cause 3 AM Hypoglycemia but Negative Feedback Mechanism cause Early Morning Hyperglycemia
SOMOGYI EFFECT
Controlled Sugar Level throughout the night but with Early Morning Hyperglycemia
DAWN PHENOMENON
Hyperglycemia at 3AM with Early Morning Hyperglycemia despite Insulin Admin
WANING OF INSULIN
3 AM Hyperglycemia with Very High Early Morning Hyperglycemia
WANING & DAWN PHENOMENON
Pathognomonic Triad of DKA
HYPERGLYCEMIA, KETONEMIA, HAGMA
Pathogenesis of DKA
UNCONTROLLED HYPERGLYCEMIA causes KETOACIDOSIS
Labs requested in DKA
URINE KETONES, ABG, SERUM GLUCOSE
Fruity Breath in DKA
KETONE BODIES (ACETOACETATE and BETA-HYDROXY- BUTYRATE)
FActors that can Incite DKA
INFECTION, ISCHEMIA, INFARCTION, IGNORANCE, INTOXICATION
Most Appropriate Treatment in DKA
FLUID REPLACEMENT and INSULIN DRIP
Underlying Cause of Pheochromocytoma
Excess Catecholamine Production from Neoplastic Chromaffin Cells in Adrenal Medulla
Headaches in Pheochromocytoma
DUE TO INCREASED BLOOD PRESSURE
Diaphoresis, Tremors, Tachycardia, and Hypertension in Pheochromocytoma
DUE TO EXCESSIVE ACTIVATION OF THE SYMPATHETIC NERVOUS SYSTEM as a result of EXCESS CATECHOLAMINES IN CIRCULATION
Classic Triad of Pheochromocytoma
TACHYCARDIA. SWEATING, HEADACHES
Most Appropriate Diagnostic Test for Pheochromocytoma
URINE VANILLYLMANDELIC ACID (URINE METANEPHRINES)
Most Appropriate Imaging Study for Pheochromocytoma
ABDOMINAL CT SCAN
Most Appropriate Treatment for Pheochromocytoma
SURGICAL RESECTION
Drugs Given Prior to Surgical Intervention in Pheochromocytoma
PHENOXYBENZAMINE (Irreversible Alpha Blocker), PHENTOLAMINE (Reversible Alpha Blocker) or LABETALOL (Beta Blocker)
Cancer Syndromes associated with Pheochromocytoma? Multiple Endocrine Neoplasia (MEN)?
MEN IIa: PCC, Medullary Thyroid Cancer, PTH; MEN IIb: PCC, Medullary Thyroid Cancer, Neuromas
Rule of 10s for Pheochromocytoma
10% bilateral, 10% extra-adrenal, 10% malignant, 10% familial, 10% pediatric, 10% without BP elevation
Underlying Cause for Conn Syndrome (Primary HyperAldosteronism)
EXCESS ALDOSTERONE PRODUCTION from ADRENAL CORTEX TUMOR
Increased Aldosterone, Decreased Renin, Increased ECF Volume, No Change in Sodium Excretion, Absent Edema, Etiology - Adrenal Tumor (Conn Syndrome)
PRIMARY HYPERALDOSTERONISM
Increased Aldosterone, Increased Renin, Increased ECF Volume, Decreased Sodium Excretion, Presence of Edema, Etiology - RENIN-SECRETING TUMOR, RENAL ARTERY STENOSIS
SECONDARY HYPERALDOSTERONISM
Persistent Hypertension in Conn Syndrome
DUE TO EXCESSIVE ALDOSTERONE PRODUCTION
Normal Sodium Excretion and No Edema despite of Increased ECF Volume
due to SODIUM ESCAPE PHENOMENON (Increased BP -> Inc ANP production -> Normalization of Sodium Excretion and Prevents Edema)
Fatigue and Muscle Weakness in Conn Syndrome
due to DECREASED POTASSIUM LEVELS
Polyuria in Conn Syndrome
DECREASED POTASSIUM IMPAIRS URINE CONCENTRATING ABILITY (Counter Current Multiplier Uses Na-K-Cl Co-Transport)
Metabolic Alkalosis in Conn Syndrome
- Hydrogen ion loss into urine and migration into potassium-depleted cells 2. Potassium deficiency increases capacity of Proximal Convoluted Tubule to Reabsorb Filtered Bicarbonate
Most appropriate Treatment in Conn Syndrome
SURGICAL REMOVAL OF ADRENAL MASS
Management for Unresectable Tumor in Conn Syndrome
ALDOSTERONE ANTAGONISTS (SPINOROLACTONE and EPLERENONE)
Underlying Cause of Cushing’s Syndrome
EXCESS CORTISOL PRODUCTION FROM ADRENAL CORTEX TUMOR
Most common Cause of Cushing Syndrome
IATROGENIC (EXCESS STEROID INTAKE)
Increased Cortisol, Decreased ACTH, No effect on High-Dose Dexa Suppression, Eti: CORTISOL PRODUCING ADRENAL TUMOR
ADRENAL CUSHING SYNDROME
Increased Cortisol, Increased ACTH, Suppressed High-Dose Dexa Suppression, Eti: ACTH-Producing Pituitary Tumor
PITUITARY CUSHING SYNDROME
Increased Cortisol, Increased ACTH, No effect on High-Dose Dexa Suppression, Etio: ACTH-Producing Lung Tumor
ECTOPIC CUSHING SYNDROME
Hypertension in Cushing Syndrome
- Excess cortisol -> Inc Vascular Responsiveness to Catecholamines -> Inc Total Peripheral Resistance 2. At High Doses, Glucocorticoids display mineralocorticoid effects -> SALT and WATER RETENTION
Central Obesity in Cushing Syndrome
Catabolism of Skin Proteins lead to Weakening and Rupture of Collagen Fibers in the Dermis
Easy Bruising and Violaceous Abdominal Striae in Cushing Syndrome
EXCESS CORTISOL LEADS TO INSULIN RESISTANCE and ADIPOSE TISSUE DEPOSITION at CHARACTERISTIC SITES (MOON FACIES, BUFFALO HUMP)
Acne and Hirsutism in Cushing’s Syndrome
- Excess adrenal androgens 2. Excess insulin stimulates ovarian theca cells to produce androgens
Proximal Weakness and Edema in Cushing’s
Due to EXCESS PROTEIN CATABOLISM and PROTEIN DEPLETION
Most appropriate treatment in Cushing’s
SURGICAL RESECTION of the ADRENAL MASS
Management for Surgically Unresectable Tumors
KETOCONAZOLE, METYRAPONE
Underlying Cause of Addison’s Disease
AUTOIMMUNE DESTRUCTION OF ADRENAL GLANDS
Increased CRH, Increased ACTH, Decreased Cortisol, Decreased Aldosterone, Decreased Androgens, (+) Hypotension, Dark Skin Color, Etio: AUTOIMMUNE ADRENALITIS
PRIMARY ADRENAL INSUFFICIENCY
Increased CRH, Decreased ACTH, Decreased Cortisol, Normal Aldosterone, Decreased Androgens, (-) Hypotension, Pale Skin Color, Etio: PITUITARY NOT SECRETING ACTH
SECONDARY ADRENAL INSUFFICIENCY
Decreased CRH, Decreased ACTH, Decreased Cortisol, Normal Aldosterone, Decreased Androgen, (-) Hypotension, Pale Skin Color, Etio: STEROID WITHDRAWAL
TERTIARY ADRENAL INSUFFICIENCY
Muscle Weakness, Weight Loss and Anorexia in Adrenal Insufficiency
DECREASED ENERGY MOBILIZATION DUE TO DECREASED CORTISOL
Skin Darkening in Adrenal Insufficiency
INCREASED ACTH SECRETION LEADS TO EXCESS POMC-DERIVED HORMONES (a-MSH, b-MSH)
Orthostatic Hypotension in Adrenal Insufficiency
Decreased Aldosterone -> DECREASED RESPONSIVENESS OF RAA
Decreased Sodium and Increased Potassium Levels in Adrenal Insufficiency
DECREASED ALDOSTERONE ACTIVITY
Decreased Glucose Level in Adrenal Insufficiency
DECREASED CORTISOL causes INCREASED INSULIN SENSITIVITY
Decreased Pubic Hair in Adrenal Insufficiency
DUE TO ADRENAL ANDROGEN DEFICIENCY
Signs of Androgen Deficiency more seen in Females with Adrenal Insufficiency
ADRENALS are MAIN SOURCE OF ANDROGENS IN FEMALES (TESTIS in MALES)
Occurence of severe hypotension (shock) as a result of extreme adrenal hormone deficiency (in patients with Depressed HPA axis)
ADRENAL CRISIS
Adrenal Crisis in setting of Fulminant Meningococcemia
WATERHOUSE-FRIDERICHSEN SYNDROME (due to BILATERAL ADRENAL HEMORRHAGE)
Most Appropriate Diagnostic Test Adrenal Insufficiency
ACTH STIMULATION TEST (COSYNTROPIN TEST)
Interpretation of ACTH STIMULATION TEST (COSYNTROPIN TEST)
PRIMARY AI: Low Cortisol + Low ACTH; SECONDARY/TERTIARY AI: Low Cortisol + High ACTH
Most Appropriate Treatment in Adrenal Insufficiency
GLUCOCORTICOID and MINERALOCORTICOID REPLACEMENT, AGGRESSIVE HYDRATION
Most common Cause of Acute Pancreatitis
GALLSTONES > ALCOHOLIC BINGE DRINKING
Other important Cause of Acute Pancreatitis
Trauma, Steroids, Mumps, Autoimmune, Scorpion Bites, Hyperlipidemia, Drugs (Antivirals)
Characteristic Signs on PE of Acute Pancreatitis
GRAY TURNER (FLANK) & CULLEN (PERIUMBILICAL)
Most Common Appropriate Diagnostic Test
SERUM AMYLASE (MORE SENSITIVE) & SERUM LIPASE (MORE SPECIFIC)
Important Imaging Study in Acute Pancreatitis
ABDOMINAL CT SCAN (SENTINEL LOOPS)
Most Appropriate Treatment for Acute Pancreatitis
BOWEL REST (NPO), HYDRATION, ANALGESICS
Most Appropriate Analgesic for Treatment of Acute Pancreatitis
MEPERIDINE (DOES NOT CAUSE SO DYSFUNCTION)
Complications of Acute Pancreatitis
Hemorrhage, Pseudocyst, Chronic Pancreatitis
Criteria used for Prognostication in Acute Pancreatitis
RANSON’S CRITERIA: AT PRESENTATION (GALAW) - Glucose >200mg/dL, Age >55, LDH >250u/L, AST >250u/L, WBC >16,000/mm3; AT 48 HOURS (CHOBBS) - Calcium 10%, pO2 5mg/dL, Base deficit >5mg/dL, Sequestration of Fluid ls >6L
Prognostication of Acute Pancreatitis using Ranson’s Criteria
0-2: 2% mortality, 3-4: 15% mortality, 5-6: 40% mortality, 7-8: 100% mortality
Antibiotics indicated for Acute Pancreatitis
ONLY INDICATED IN SEVERE PANCREATITIS WHEN >30% NECROSIS ON CT SCAN
Indication for Surgery in Acute Pancreatitis
PSEUDOCYST, ABSCESS, BILIARY PANCREATITIS
Clinical Presentation of Chronic Pancreatitis
ABDOMINAL PAIN WITH SIGNS OF MALABSORPTION DUE TO PANCREATIC INSUFFICIENCY
Most Common Cause of Chronic Pancreatitis
LONG TERM ALCOHOL ABUSE
Treatment for Chronic Pancreatitis
DIETARY MODIFICATION (SMALL, LOW-FAT MEALS), ENZYME REPLACEMENT (PANCRELIPASE)
Risk Factors for Esophageal Adenocarcinoma
ACHALASIA, BARRETT ESOPHAGUS, CIGARETTE SMOKING, DIVERTICULA, ETHANOL, FAMILIAL
Most Appropriate Diagnostic Test for Esophageal Adenocarcinoma
BARIUM SWALLOW, followed by EGD with BIOPSY
Seen on Biopsy in Esophageal Adenocarcinoma
SQUAMOCOLUMNAR METAPLASIA (BARRETT ESOPHAGUS) and NEOPLASTIC CHANGES (INVASION)
Most Appropriate Treatment for Esophageal Adenocarcinoma
ESOPHAGECTOMY with GASTRIC PULL-UP with or without CHEMORADIATION (Controversial)
2 Types of Esophageal Cancer? Associated conditions?
BARRETT’S ESOPHAGUS = ESOPHAGEAL ADENOCARCINOMA; PLUMMER-VINSON SYNDROME = SCCA
Localization and Incidence for Esophageal AdenoCarcinoma and SCCA
NOW EQUAL IN INCIDENCE; ESOPHAGEAL ADENOCARCINOMA in Distal 3rd, ESOPHAGEAL SCCA in Middle 3rd
Differentiate Esophageal Cancer from Achalasia clinically
ACHALASIA: dysphagia to solids and liquids simultaneously; ESOPHAGEAL CA: dysphagia first to solids progressing to liquids
Alcoholic who had Frequent Retching and Vomiting leading to Severe Hematemesis
ESOPHAGEAL RUPTURE
Differentiate 2 Most Likely Cause of Esophageal Rupture
MALLORY-WEISS SYNDROME: Partial Thickness tearing at GEJ; BOERHAAVE’S SYNDROME: ANTIBIOTICS, SURGERY, IV HYDRATION (almost 100% mortality)
Underlying Pathology in PUD
GASTRIC and HYPERSECRETION LEADING TO ULCERS
Most Appropriate Diagnostic Test for PUD
ENDOSCOPY with BIOPSY
Conditions encompassed by PUD
GASTRIC ULCERS and DUODENAL ULCERS
Most common location of PUD
DUODENAL BULB
Differentiate Gastric Ulcer and Peptic Ulcer
GASTRIC ULCER: Pain worse on food intake, no nocturnal pains; PEPTIC ULCER: Pain relieved with food intake, awakens patient at night
Most appropriate treatment for PUD
PROTON PUMP INHIBITORS; if (+) H Pylori: OMEPRAZOLE + CLARITHROMYCIN + AMOXICILLIN
Possible Complications for PUD
HEMORRHAGE > PERFORATION > GASTRIC OUTLET OBSTRUCTION
Treatment of PUD when Refractory to Medical Management
DUODENAL ULCER: Truncal Vagotomy with Pyloroplasty; GASTRIC ULCER: Bilroth I or II Reconstruction
PUD patient continues to be Refractory to Management. Pancreatic mass on CT scan
GASTRINOMA (ZOLLINGER-ELLISON SYNDROME)
Most common anatomic location of Gastrinomas
PASSARO’S TRIANGLE: junctions of cystic duct/ CBD, 2nd/3rd portion of duodenum, head/ neck of pancreas)
Most Appropriate Diagnostic Test for Gastrinomas
PENTAGASTRIN STIMULATION TEST, SECRETIN STIMULATION TEST
Usual Location of Ulcers in Zollinger-Ellison Syndrome
Simultaneous, recurrent gastric and duodenal ulcers (postbulbar)
Underlying pathology in Chronic Liver Disease
ADVANCED LIVER CIRRHOSIS COMPLICATED by PORTOSYSTEMIC SHUNTING
Most common cause of Chronic Liver Disease
ALCOHOLISM and VIRAL HEPATITIS
Differentiate among Common Causes of Chronic Liver Disease
AST/ALT RATIO > 2 in ALCOHOLIC LIVER DISEASE = 1 in VIRAL HEPATITIS
Histopathologic Hallmark seen in Alcoholic Liver Disease compared to Viral Hepatitis
MALLORY BODIES (Malloy Lasingero) = ALD, COUNCILMAN BODIES (Councillor Manyakis) = VIRAL HEPATITIS
3 Stages of Alcoholic Liver Disease
STEATOSIS, HEPATITIS, CIRRHOSIS
Other Signs and Symptoms of Liver Disease
CLD: palmar erythema, testicular atrophy, spider angioma, Duputyren contracture; PH: hemorrhoids, caput medusae, varices ruptured esophageal varices
Gynecomastia, Spider Angiomata and Palmar Erythema in Chronic Liver Disease
Due to High Circulating Estrogen Levels
Muehrcke Nails, Peripheral Edema and Prolonged Bleeding Time in Chronic Liver Disease
Due to HYPOALBUMINEMIA, HYPOPROTEINEMIA
Thrombocytopenia, Anemia and Leukopenia in Chronic Liver Disease
Due to HYPERSPLENISM
Ruling Out Other Causes of Ascites other than Portal Hypertension
SERUM ASCITES ALBUMIN GRADIENT (SAAG): >1.1 - Portal Hypertension, <1.1 - Malignancy or Infection
Most Appropriate Treatment for Chronic Liver Disease
TIPS PROCEDURE
Definitive Treatment for Chronic Liver Disease
LIVER TRANSPLANT
Complications if Chronic Liver Disease is Left Untreated
Massive UGIB, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, bacterial peritonitis
Signs if Hepatic Failure
HYPERAMMONEMIA, FETOR HEPATICUS
Hepatic Encephalopathy and Asterixis in Chronic Liver Disease
ACCUMULATION OF AMMONIA IN CNS
Responsible for Fetor Hepaticus
MUSTY, FECAL SMELL due to ACCUMULATION OF MERCAPTANS
Treatment of Hepatic Encephalopathy
LACTULOSE (promotes bowel movement and excretion of Ammonia, acidification of colon, deactivation of colonic bacteria), Protein restriction (branched-chain amino acid), Neomycin
Underlying pathology in Ulcerative Colitis
INFLAMMATORY BOWEL DISEASE
Types of Ulcerative Colitis
ULCERATIVE COLITIS & CROHN DISEASE
Can be ANYWHERE in GIT, with SKIP LESIONS and RECTAL SPARING, TRANSMURAL inflammation, COBBLESTONE MUCOSA, NONCASEATING GRANULOMAS
CROHN’s DISEASE
Found in COLON only, MUCOSAL inflammation, LEAD PIPE colon, PSEUDOPOLYPS, CRYPT ABSCESSES
ULCERATIVE COLITIS
Extracolonic Manifestation associated with Ulcerative Colitis
Arthritis, Episcleritis, Uveitis, Pyoderma Gangrenosum
Increased Risk of Malignancy in Ulcerative Colitis
COLON CANCER
Bacterial Infection causing Flare-Ups in Ulcerative Colitis
CLOSTRIDIUM DIFFICILE
Complications of Ulcerative Colitis? Definitive treatment?
EXSANGUINATION, TOXIC MEGACOLON; Definitive Tx - TOTAL COLECTOMY
Most Likely Cause of Acute Tubular Necrosis
RENAL HYPOPERFUSION due to HYPOVOLEMIA (hemorrhage), RHABDOMYOLYSIS
Other Laboratory Tests requested in ATN
SERUM ELECTROLYTES, BUN, CREA
Differentiate Azotemia from Uremia
AZOTEMIA: Biochemical (Inc Urea); UREMIA: Clinical Signs and Symptoms
3 Important Causes of Azotemia
PRERENAL DISEASE, INTRINSIC RENAL DISEASE and POSTRENAL DISEASE (OBSTRUCTIVE UROPATHY)
BUN/Crea ratio >20, Fe Sodium <1%, due to Hypovolemia, Hemorrhage
PRERENAL AZOTEMIA
BUN/Crea Ratio 2%, due to PSGN, Drugs, HTN
INTRINSIC RENAL
BUN/Crea ratio 10-20, Fe Sodium Intermediate, due to Prostate, Cervical Cancer
OBSTRUCTIVE UROPATHY
Continuing significant irreversible reduction in nephron number
CHRONIC KIDNEY DISEASE
Most common cause of Chronic Kidney Disease
DIABETES MELLITUS
Staging for Chronic Kidney Disease
Stage 0: with Risk Factor, Stage 1: GFR >90, Stage 2: GFR 60-89, Stage 3: GFR 30-59, Stage 4: GFR 15-29, Stage 5: GFR <15 (ESRD)
Indications for Dialysis in CKD
ACIDOSIS, ELECTROLYTES (Hyperkalemia), Ingestion of Toxins, Overload, Uremia
2 Modes of Dialysis
HEMODIALYSIS (Tesio Catheter and AV graft) & PERITONEAL DIALYSIS (Tenchkoff Catheter)
Anemia in CKD? Type of Anemia?
Inability to produce EPO causes NORMOCYTIC, NORMOCHROMIC ANEMIA
Secondary Hyperparathyroidism in CKD
Failing kidneys FAIL TO REABSORB CALCIUM -> HYPOCALCEMIA
Vitamin D supplementation in CKD
Inability to form active Vitamin D (1,25-DHCC) due to kidney damage
Clinical Effect of Hypocalcemia, Hyperphosphatemia and Low Vitamin D in CKD
RENAL OSTEODYSTROPHY (CHONDROCALCINOSIS, OSTEOPENIA)
Most common Cause of Death in CKD
CAD/MI (ESRD is a CAD equivalent)
Medications Given to Prevent Cardiac Complications in CKD
BETA-BLOCKERS, ACE-Inhibitors, STATINS
Most common cause of Acute Pyrlonephritis
ESCHERICHIA COLI
Most Appropriate Treatment for Acute Pyelonephritis
EMPIRIC ANTIBIOTIC THERAPY (QUINOLONES)
Complication of Acute Pyelonephritis in Diabetics
RENAL PAPILLARY NECROSIS
Facultative Gram-Negative Rods with Swarming Motility in Urine Culture in Acute Pylonephritis
PROTEUS MIRABILIS
Infections more common on Females in Acute Pyelonephritis
Females have SHORTER URETHRA
Underlying pathology in Nephrotic Syndrome
IN SITU IMMUNE COMPLEX FORMATION/ DEPOSITION
Most Common Cause of Nephrotic Syndrome in Adults
MEMBRANOUS NEPHROPATHY
Most Common Cause of Nephrotic Syndrome in Children
MINIMAL CHANGE DISEASE
Renal Biopsy in Nephrotic Syndrome
LM: Diffuse capillary wall thickening, EM: Subepithelial deposits, IF: Granular deposits
Nephrotic Range Proteinuria
> 3.5g protein in 24H urine collection
Most Appropriate Treatment for Nephrotic Syndrome
STEROIDS (PREDNISONE): Better response in Minimal Change Disease
Complications arising from Nephrotic Syndrome
SPONTANEOUS BACTERIAL PERITONITIS, THROMBOMBOLIC EVENTS, HYPERLIPIDEMIA
If Nephrotic Syndrome patient Unresponsive to Steroids after 2 Months
FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Most Common Cause of Nephrotic Syndrome in Children
MINIMAL CHANGE DISEASE (LIPOID NEPHROSIS)
Types of Renal Tubular Acidosis
TYPE I RTA, TYPE II RTA, TYPE IV RTA
Most Common Cause of RTA
TYPE I RTA: Sporadic, Hep B or Hep C; TYPE II RTA: Multiple Myeloma, Amyloidosis; TYPE IV RTA: DM, Hypoaldosteronism
Pathophysiologic Mechanism for RTA
TYPE I RTA: Inability to secrete H+ in DCT; TYPE II RTA: Inability to reabsorb HCO3 in PCT; TYPE IV RTA: Decreased Aldosterone
High Urine pH (Basic), (+) STONES, Low Potassium, Diagnosis by Acid Load (give NH4Cl), Tx via HCO3 + K tabs
TYPE I RTA (Distal)
Low Urine pH (Acidic), (-) Stones, Low Potassium, Diagnosis by HCO3 LOAD (Give HCO3), Tx via HCO3 + K tabs + diuretics (HCTZ)
TYPE II RTA (PROXIMAL)
Low Urine pH (Acidic), (-) Stones, HIGH POTASSIUM, Diagnosis by Na Restriction (High Urine Na), Tx via Fludrocortisone
TYPE IV RTA (DM)
Defect at Thick Ascending Loop, Na-K-2Cl Symport Channel, more on Children, Normal/ Increased Urine Ca2+ (Stones), Impaired Concentrating Ability, Dec GFR (AS IF LOOP DIURETIC ABUSER, MORE SEVERE)
BARTERR’S SYNDROME
Defect at Distal Convoluted Tubule, Na-Cl Symport Channel, more on Adults, Dec Urine Ca2+ (No Stones), Normal Concentrating Ability, Normal GFR (AS IF THIAZIDE DIURETIC ABUSER)
GITELMAN’S SYNDROME
Underlying Pathology in SLE
CHRONIC MULTISYSTEM AUTOIMMUNE DISEASE
Type of Hypersensitivity in SLE
TYPE III HYPERSENSITIVITY
Most Sensitive and Specific Serologic Tests for SLE
MOST SENSITIVE: ANA; MOST SPECIFIC: anti-dsDNA or anti-Smith
Diagnostic Criteria for SLE
AT LEAST 4/11: Serositis, Oral Ulcers, ANA, Photosensitivity, Blood, Renal, Arthritis, Immunologic, Neuropsychiatric, Malar Rash, Discoid Rash
Most Common Criterion for SLE
HEMATOLOGIC CHANGES (LEUKOPENIA)
Drugs causing Similar Presentation as SLE? Auto- antibodies associated?
HYDRALAZINE, ISONIAZID, PROCAINAMIDE, PENICILLAMINE; ANTI-HISTONE ANTIBODIES
False Positive Syphilis Test in SLE
Anti- Cardiolipin Antibodies; RPR is embedded in Cardiolipin
Complications in Pregnant SLE patient? Pathogenesis?
RECURRENT ABORTIONS due to APAS (due to Lupus Anticoagulant and AntiCardiolipin Antibodies)
Most Appropriate Treatment for Acute Flare-Ups in SLE
CORTICOSTEROIDS
Most Appropriate Treatment for Cutaneous Lesions
ANTIMALARIALS with or without CORTICOSTEROIDS (Low Dose)
Most Appropriate Treatment to Induce Disease Remission in SLE
IMMUNOSUPPRESSIVES (CYCLOPHOSPHAMIDE) + CORTICOSTEROIDS
Management for Development of Unexplained Proteinuria and Hematuria
RENAL BIOPSY
Most Catastrophic Organ Involvement in SLE
SLE NEPHRITIS
Various Forms of Renal Involvement
I: Minimal Mesangial 10-25%, II: Mesangial Proliferative, III: Focal Proliferative 20-35%, IV: Diffuse Proliferative 35-60% (Most Common/ Most Severe; HP- Wire-Loop Lesions), V: Membranous 10-15% (Nephrotic Change Proteinuria)
Underlying Pathology in Osteoarthritis
CHRONIC, SLOWLY PROGRESSIVE, EROSIVE DAMAGE TO JOINT SURFACES -> LOSS OF ARTICULAR CARTILAGE
Etiology of Osteoarthritis
DIRECTLY PROPORTIONAL to INCREASING AGE and TRAUMA to the JOINT (Most Common Cause of Joint Disease)
Most Appropriate Diagnostic Test in Osteoarthritis
XRAY OF AFFECTED JOINTS (Joint Space Narrowing, Osteophytes, Bone Cysts)
Most Appropriate Treatment in Osteoarthritis
WEIGHT LOSS, MODERATE EXERCISE, ACETAMINOPHEN (Best Initial Analgesic), INTRAARTICULAR STEROIDS IF THERE IS NO PAIN CONTROL, JOINT REPLACEMENT for SEVERE DISEASE
Differentiate Rheumatoid Arthritis from Osteoarthritis
RHEUMATOID ARTHRITIS: Bilateral, Symmetrical Joint Involvement (usually MCP joints), Morning Stiffness >30min, Autoimmune Phenomena (Rheumatoid Nodules, Episcleritis, Vasculitis)
Underlying Pathology in Gout
Defect in Urate Metabolism due to Overproduction (Idiopathic, Increased turnover of cells, enzyme deficiency) or underexcretion (Renal Insufficiency, Acidosis, Thiazides, Aspirin)
Most Acurate Diagnostic Test in Gout
Joint Aspiration (Needle-Shaped Crystals with Negative Bifringence on Polarized Light Microscopy)
Most appropriate treatment of Gout in ER
NSAIDS and COLCHICINE
Safe Drug for Chronic Gout with Renal Insufficiency
ALLOPURINOL
Calcium pyrophosphate deposition disease
PSEUDOGOUT
Finding on Joint Aspiration in Gout
POSITIVELY BIFRINGENT RHOMBOID-SHAPED CRYSTALS
Most Common Cause of Atypical Pneumonia
Mycoplasma (Most Common), Legionella, Chlamydia
Diagnostic Test to Confirm Clinical Impression
MYCOPLASMA: IgM Titer or Cold Agglutinin Test; LEGIONELLA: Urinary Antigen Test; CHLAMYDIA: Serology or Antigen Detection
Most Likely Cause of Disease in Atypical Pneumonia
MYCOPLASMA (Skin Rash, Hemolysis, Arthralgia)
Other Clinical Clinical Cues to Rule Out Other Causes of Atypical Pneumonia
LEGIONELLA: Hyponatremia, Diarrhea; CHLAMYDIA: Atherosclerosis
Most Appropriate Treatment in Atypical Pneumonia
Empiric Therapy with AZITHROMYCIN
Most Common Cause of High Grade Fever, Rusty Sputum, and Lobar Pneumonia
STREPTOCOCCUS PNEUMONIAE
Most Common Cause of Pneumonia with Currant Jelly Sputum
KLEBSIELLA PNEUMONIAE
Pathologic Stages of Typical Bacterial Pneumonia
CONGESTION, RED HEPATIZATION, GREY HEPATIZATION, RESOLUTION
Indication for Pseudomonas Coverage in CAP
PROLONGED BROAD-SPECTRUM ANTIBIOTIC THERAPY, BRONCHIECTASIS, MALNUTRITION, STEROID THERAPY
Admission Criteria for patient with CAP
Confusion, Uremia, RR>30, low BP, Age >65 (CURB-65 CRITERIA, If 2 or more present, ADMIT)
Light’s Criteria: LDH >200, LDH/Serum Ratio >0.6, Protein/Serum Ratio >0.5, Ex: Pneumonia, Cancer, Infections, RHD
EXUDATE
Light’s Criteria: LDH <0.5, Ex: CHF, Cirrhosis, Renal Failure
TRANSUDATE
Underlying pathology in COPD
Destruction of Normal Alveoli-Capillary structures and enlargement of Airspace
2 Disease Components in Spectrum of COPD
EMPHYSEMA and CHRONIC BRONCHITIS
Most Important Risk Factor of COPD
SMOKING
Other Important Diagnostic Test for COPD? Expected Findings?
PULMONARY FUNCTION TEST showing DECREASED FEV1 and FEV1/FVC ratio
Most Common Pattern of Involvement in COPD
CENTRIACINAR EMPHYSEMA OF UPPER LOBES
Congenital Enzyme Deficiency associated with COPD? Morphologic pattern?
ALPHA-1 ANTITRYPSIN DEFICIENCY, with BIBASILAR PANACINAR EMPHYSEMA and LIVER CIRRHOSIS
Drug of Choice for COPD
INHALED BRONCHODILATOR + ANTICHOLINERGIC; INHALED CORTICOSTEROIDS
Only Treatments shown to Improve Survival in COPD
SMOKING CESSATION and HOME OXYGEN THERAPY
Right-Sided CHF in COPD
COR PULMONALE (COPD STAGE V)
Most Common Cause of Exacerbation in COPD
INFECTIONS (H. Influenzae, Influenza virus)
Preventive Measures for COPD patients? Level of Prevention?
PNEUMOCOCCAL, Hib and INFLUENZA VACCINATIONS (PRIMARY PREVENTION)
Drug of Choice for COPD with Comorbid Cardiac Conditions
IPRATROPIUM (BETA-AGONISTS cause TACHYCARDIA and ARRHYTHMIAS)
Underlying Pathology in PE
DVT travels to LUNGS and OBSTRUCTS PULMONARY VASCULATURE
Risk Factors for PE
HYPERCOAGULABILITY: Estrogens, Malignancy, Genetic Diseases; STASIS: Prolonged Immobilization; ENDOTHELIAL INJURY: Trauma, previous DVT (VIRCHOW’s TRIAD)
Most Appropriate Diagnostic Test for PE? Expected Finding?
VENTILATION-PERFUSION SCAN (V/Q scan); Multiple Perfusion Defects with Normal Ventilation (V/Q ratio)
Gold Standard for Diagnosis of PE
PULMONARY ANGIOGRAPHY (SPIRAL CT?)
Most Common Acid-Base Disorder associated with PE
RESPIRATORY ALKALOSIS
Most Common ECG finding in PE
SINUS TACHYCARDIA (also NSSTTWC or S1Q3T3 strain pattern)
Most Appropriate Treatment for PE
ANTICOAGULATION
Most Appropriate Treatment for PE patients with Contraindications
IVC FILTER
Most Common Cause of Death in PE
PROGRESSIVE RIGHT-SIDED HEART FAILURE
Causative Agent of TB
MYCOBACTERIUM TUBERCULOSIS
Most Appropriate Diagnostic Test for TB
SPUTUM AFB x 3
Phases of Infection of TB?
PRIMARY COMPLEX and REACTIVATION TB
Mode of Transmission for TB
AIRBORNE DROPLETS
Asymptomatic Case Detection for TB
PPD or MANTOUX test
Chest XRay Findings in TB
SIMON’S FOCUS, CICATRICIAL CHANGES, CAVITATION at LUNG APEX
Most Appropriate Treatment for TB
2 HRZE/ 4HR in 6 months
Most Effective Treatment Strategy
DOTS
Adverse Effects associated with TB Treatment
INH: Neuro/Hepatotoxicity, RMP: RO urine, PZA: Arthralgia, Hepatotoxicity, EMB: Retrobulbar Neuritis
Underlying Pathology in BAIAE
REVERSIBLE AIRWAY INFLAMMATION and OBSTRUCTION
Type of Immune Reaction causing BAIAE
TYPE I REACTION (IgE Mediated)
Bronchospasm in BAIAE
IgE-mediated degranulation of Mast Cells causing HISTAMINE RELEASE
HP Hallmarks in BAIAE
CURSCHMANN’s SPIRALS, CHARCOT-LEYDEN CRYSTALS
Best Initial Test for Diagnosis of BAIAE
PULMONARY FUNCTION TEST: 12% improvement with FEV1 after Beta-Agonist)
Next best Diagnostic Test if Asthma patient is Not in Exacerbation
METHACOLINE CHALLENGE: >20% decrease in FEV1
Poor Prognostic Factors for Asthma
PULSUS PARADOXUS, RESPIRATORY FATIGUE, CYANOSIS
ABG in BAIAE
EARLY STAGE: Repiratory Alkalosis, Normal pO2, LATE STAGE: Respiratory Acidosis, IMPENDING RESPIRATORY FAILURE: Normal ABG
Acute Exacerbation of Asthma Not Responding to Standard Treatments
STATUS ASTHMATICUS
Treatment of Status Asthmaticus
IV HYDROCORTISONE, NEBULIZED EPINEPHRINE or ALBUTEROL, THEOPHYLLINE, MgSO4
Types of Medication in Asthma Management
RELIEVERS (Reduce Bronchospasm): SABA, Ipratropium, Theophylline, IV Hydrocortisone; CONTROLLERS (Reduce Inflammation): Steroids, LABA, Leukotriene Antagonists, Mast Cell Stabilizers, anti-IgE antibodies
2 Main Morphologic Forms of Lung Cancer
SMALL CELL LUNG CANCER, NON-SMALL CELL LUNG CANCER
Most Significant Risk Factor for Lung Cancer
CIGARETTE SMOKING
Next Step in Management of Lung Cancer
CHEST XRAY
Gynecomastia, Clubbing and Acanthosis Nigricans in Lung Cancer
PARANEOPLASTIC SYNDROMES
Most Appropriate Diagnostic Test after Imaging Studies
LUNG BIOPSY
Centrally-Located Lung Mass upon CXray in Lung Cancer
SMALL CELL LUNG CANCER, SQUAMOUS CELL LUNG CANCER
Differentiate Lung Cancer on Basis of Paraneoplastic Syndromes
SMALL CELL LUNG CANCER: Ectopic Cushing Syndrome, SIADH, Lambert-Eaton Myasthenia; SQUAMOUS CELL LUNG CANCER: Hypercalcemia, Clubbing, Gynecomastia
Most Appropriate Treatment for Lung Cancer
CHEMOTHERAPY with or without RADIOTHERAPY
Complications of Lung Cancer
SUPERIOR VENA CAVA SYNDROME, PANCOAST TUMOR leading to HORNER SYNDROME, AIRWAY OBSTRUCTION, HOARSENESS
Prognosis for Lung Cancer
POOR (5-Year Survival Rate 10%)
Underlying Pathology for Colorectal Cancer
BLEEDING COLORECTAL MASS causing OBSTRUCTION
Most Appropriate Diagnostic Test for Colorectal Cancer
COLONOSCOPY with BIOPSY
Appropriate Screening Test for those at Risk for Colorectal Cancer
FOBT (Yearly), SIGMOIDOSCOPY (Every 5 years), COLONOSCOPY (Every 10 years)
Familial Colon Cancer Syndrome associated with Mutation of APC gene
FAMILIAL ADENOMATOUS POLYPOSIS
Diagnosis for Colorectal Cancer
VISUALIZING: 100 Polyps during Colonoscopy
FAP plus Brain Tumors (Medulloblastoma), Café-au-lait spots and Basal Cell Carcinoma
TURCOT SYNDROME
FAP plus extraintestinal tumors: Osteomas, Nasopharyngeal Fibroma, Lipoma
GARDNER SYNDROME
Hyperpigmented spots on Lips/ Bucc Mucosa and Hamartomatous Polyps (Not Premalignant)
PEUTZ-JEGHERS SYNDROME
Hereditary Non-Polyposis Cancer due to Defective Mismatch Repair (Colon Cancer + Endometrial Cancer)
LYNCH SYNDROME
Differentiate Right-Sided and Left-Sided Colon Cancer
RIGHT-SIDED: Fatigue and weakness due to Iron Deficiency Anemia; LEFT-SIDED: Occult Bleeding, Changes in Bowel Habits or Cramping Left Lower Quadrant discomfort
Most Important Risk Factor for Colorectal Cancer
DIETARY HABITS (Low Fiber, High Refined Carbohydrates/ Fat)
Most Important Prognostic Factor of Colorectal Cancer
Depth of Invasion, Presence or Absence of Lymph Node Metastases
Describe Treatment for Colorectal Cancer
LOCALIZED DISEASE: Surgery; METASTATIC DISEASE: Chemotherapy
Most Common Site of Metastasis
LIVER
Surgical Treatment Modalities based on Anatomic Location of Colorectal Cancer Tumor
CECUM, RIGHT COLON & PROXIMAL/ MID-TRANSVERSE: Right Hemicolectomy, SPLENIC FLEXURE and LEFT COLON: Left Hemicolectomy, SIGMOID/ RECTOSIGMOID: Sigmoid Colectomy, PROXIMAL RECTUM: Low Anterior Resection, DISTAL RECTUM: Abdomino Perineal Resection